bioMérieux Statistics

Total Valuation

bioMérieux has a market cap or net worth of EUR 12.15 billion. The enterprise value is 12.45 billion.

Market Cap	12.15B
Enterprise Value	12.45B

Important Dates

The last earnings date was Friday, October 25, 2024.

Earnings Date	Oct 25, 2024
Ex-Dividend Date	Jun 7, 2024

Share Statistics

bioMérieux has 118.01 million shares outstanding. The number of shares has increased by 0.20% in one year.

Current Share Class	n/a
Shares Outstanding	118.01M
Shares Change (YoY)	+0.20%
Shares Change (QoQ)	-0.34%
Owned by Insiders (%)	0.05%
Owned by Institutions (%)	17.82%
Float	43.73M

Valuation Ratios

The trailing PE ratio is 29.69 and the forward PE ratio is 23.51. bioMérieux's PEG ratio is 2.16.

PE Ratio	29.69
Forward PE	23.51
PS Ratio	3.19
PB Ratio	3.14
P/TBV Ratio	n/a
P/FCF Ratio	77.71
P/OCF Ratio	n/a
PEG Ratio	2.16

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.92, with an EV/FCF ratio of 79.62.

EV / Earnings	30.28
EV / Sales	3.27
EV / EBITDA	13.92
EV / EBIT	21.23
EV / FCF	79.62

Financial Position

The company has a current ratio of 2.21, with a Debt / Equity ratio of 0.14.

Current Ratio	2.21
Quick Ratio	1.20
Debt / Equity	0.14
Debt / EBITDA	0.62
Debt / FCF	3.57
Interest Coverage	162.92

Financial Efficiency

Return on equity (ROE) is 10.61% and return on invested capital (ROIC) is 8.55%.

Return on Equity (ROE)	10.61%
Return on Assets (ROA)	7.08%
Return on Capital (ROIC)	8.55%
Revenue Per Employee	277,928
Profits Per Employee	30,031
Employee Count	13,982
Asset Turnover	0.74
Inventory Turnover	1.82

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +9.29% in the last 52 weeks. The beta is 0.19, so bioMérieux's price volatility has been lower than the market average.

Beta (5Y)	0.19
52-Week Price Change	+9.29%
50-Day Moving Average	106.23
200-Day Moving Average	100.02
Relative Strength Index (RSI)	44.54
Average Volume (20 Days)	111,253

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, bioMérieux had revenue of EUR 3.81 billion and earned 411.30 million in profits. Earnings per share was 3.47.

Revenue	3.81B
Gross Profit	2.12B
Operating Income	586.50M
Pretax Income	512.40M
Net Income	411.30M
EBITDA	863.50M
EBIT	586.50M
Earnings Per Share (EPS)	3.47

Full Income Statement

Balance Sheet

The company has 272.20 million in cash and 558.50 million in debt, giving a net cash position of -286.30 million or -2.43 per share.

Cash & Cash Equivalents	272.20M
Total Debt	558.50M
Net Cash	-286.30M
Net Cash Per Share	-2.43
Equity (Book Value)	3.88B
Book Value Per Share	32.78
Working Capital	1.21B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 494.60 million and capital expenditures -338.20 million, giving a free cash flow of 156.40 million.

Operating Cash Flow	494.60M
Capital Expenditures	-338.20M
Free Cash Flow	156.40M
FCF Per Share	1.33

Full Cash Flow Statement

Margins

Gross margin is 55.72%, with operating and profit margins of 15.41% and 10.81%.

Gross Margin	55.72%
Operating Margin	15.41%
Pretax Margin	13.46%
Profit Margin	10.81%
EBITDA Margin	22.68%
EBIT Margin	15.41%
FCF Margin	4.11%

Dividends & Yields

This stock pays an annual dividend of 0.85, which amounts to a dividend yield of 0.83%.

Dividend Per Share	0.85
Dividend Yield	0.83%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	24.36%
Buyback Yield	-0.20%
Shareholder Yield	0.63%
Earnings Yield	3.37%
FCF Yield	1.29%

Dividend Details

Stock Splits

The last stock split was on September 20, 2017. It was a forward split with a ratio of 3.

Last Split Date	Sep 20, 2017
Split Type	Forward
Split Ratio	3

Scores

bioMérieux has an Altman Z-Score of 6.16.

Altman Z-Score	6.16
Piotroski F-Score	n/a